Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Indane-5-sulphonamide is a sulfonamide drug that has been shown to inhibit the growth of cancer cells in vitro and in vivo. It is an anti-diabetic agent that inhibits glucose uptake by inhibiting glycolysis. Indane-5-sulphonamide has also been shown to have inhibitory properties against aerobic glycolysis, which may be related to its acidic character. Indane-5-sulphonamide may be used as an adjuvant therapy for the treatment of cancer.</p>

<p>3-Methylnonanoic acid is a fatty acid that is involved in the metabolism of energy. It is a long-acting contraceptive and has been shown to decrease body fat and weight gain in animals. 3-Methylnonanoic acid also inhibits the uptake of fatty acids into cells, which may be due to its ability to acetylate the cytosolic protein acyl CoA synthetase 2 (ACS2). The acetylation of ACS2 may alter its conformation, leading to an inefficient method for fatty acid uptake. 3-Methylnonanoic acid can be synthesized in a two-step process by cross-coupling of methyl esters with acetonitrile. This efficient synthesis provides a practical method for producing this compound on an industrial scale.</p>

<p>Versatile small molecule scaffold</p>

<p>3-(Methylsulfonyl)aniline is a benzodioxole that inhibits tyrosine kinases. It has been shown to have potent inhibitory effects on the activity of receptor tyrosine kinases, which are involved in the transmission of signals from cell surface receptors to the interior of cells. 3-(Methylsulfonyl)aniline has been shown to be an inhibitor of various protein kinases including PDGF receptor, insulin receptor, and c-Kit. The crystal structure of 3-(methylsulfonyl)aniline bound to an ATP molecule has been determined by X-ray crystallography and shows interactions with residues in the ATP binding pocket.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Acetaminophen is a drug used to treat pain and fever. It belongs to the class of drugs called analgesics, which are also known as non-steroidal anti-inflammatory drugs (NSAIDs). Acetaminophen has been shown to be effective in the treatment of bowel disease and inflammatory bowel disease. Acetaminophen is usually given orally or intravenously, but it can also be given rectally for bowel disease. Acetaminophen is an analog of phenacetin, which was replaced in many countries because phenacetin was found to cause kidney damage. The mechanism by which acetaminophen relieves pain and reduces fever is not well understood. It may inhibit prostaglandin synthesis, block cyclooxygenase, or inhibit the production of substances that sensitize nerve endings to pain. Acetaminophen can cause allergic reactions such as skin rash, urticaria and angioedema. Acetaminophen also causes psychiatric side effects such as anxiety, mood</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Benzothiadiazole-7-carboxylic acid (BTHCA) is an activated compound that has been shown to have potent bactericidal activity. It is a member of the benzothiadiazole family of compounds, which are found in the environment and have been detected in human blood. BTHCA inhibits the enzyme hydroxycinnamoyltransferase, which leads to a decrease in shikimate production and folate levels. BTHCA also reversibly inhibits methionine synthase, leading to an accumulation of homocysteine and methionine, which are toxic substances that lead to DNA damage and cell death. This compound has been used as a pesticide for plants by blocking plant protein synthesis. Analysis of BTHCA has shown it is metabolized into p-coumaric acid, which may be responsible for its observed anti-inflammatory effects.</p>

<p>Versatile small molecule scaffold</p>

<p>Chloromethyl propyl carbonate is a pyrimidine compound that has been proposed as a potential cancer drug. It has shown high resistance to the enzymes fatty acid synthase and tenofovir and has shown antiviral properties against HIV, herpes simplex, and hepatitis B. Chloromethyl propyl carbonate inhibits the production of acyclic nucleoside phosphonates. It also inhibits fatty acid synthesis by binding to the enzyme acyl-CoA synthetase 2. Chloromethyl propyl carbonate binds to nitrogen atoms in the active site of the enzyme glutamine synthetase, thereby inhibiting its activity. The pharmacokinetic properties of chloromethyl propyl carbonate have been studied in rats and dogs; it is absorbed orally with rapid distribution into tissues, including fat, liver, kidney, lung, and brain. The drug is metabolized by carboxyesterases in the liver and excreted in urine</p>

<p>1-Chloro-2,3-dihydro-1H-indene is a kinetic inhibitor. It has been shown to bind to the enzyme quinoline synthesis and to be reactive towards chloride ions. 1-Chloro-2,3-dihydro-1H-indene is used as an intermediate in the production of styrene. This monomer has high values for constant rate kinetics and exhibits a high affinity for chloride ions, which makes it a good candidate for use in polymerization reactions. The chlorine atom can be substituted with other atoms or groups, such as ethyl groups, halides, or transfer reactions. These derivatives are also known as quinoline derivatives.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2,2-Dimethylcyclobutan-1-ol is an organic compound that belongs to the class of cyclopropanes. It is a stereospecific reaction product of 2,2-dimethylcyclopropanecarboxylic acid and sodium ethoxide in ethanol. This compound can be used as a chiral synthon for the synthesis of cyclopropane derivatives. The optical activity of this compound has been shown to be dependent on the configuration at the chiral center.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>5-(4-Bromophenyl)-5-oxovaleric acid is a molecule that has been synthesized to be used as a cancer drug. It is an amide derivative of the natural compound valproic acid and is being developed for the treatment of cancers, such as leukemia and melanoma. 5-(4-Bromophenyl)-5-oxovaleric acid has been shown to inhibit the function of integrin, which plays a role in cell adhesion and migration, with potential applications in wound healing. <br>The molecule has also been shown to have chemokine binding properties and may be useful in the treatment of diseases where chemokines are involved, such as HIV or AIDS. This compound also binds to CCR5 receptor and inhibits HIV entry into cells. The molecule has also been shown to antagonize survivin, an antiapoptotic protein that protects cells from undergoing apoptosis and prevents tumor suppression. The affinity of 5-(4-bromophenyl</p>